MedTrace Logo

Endurant CHevAr New Indication Trial: ENCHANT

NCT03320252 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2025-09-18

No results posted yet for this study

Summary

The purpose of the post-market study is to assess the clinical outcomes, safety, and performance of the Endurant Chimney Graft Technique (Endurant Stent Graft Systems used with a balloon-expandable covered stent graft) for treatment of juxtarenal aortic aneurysms with a short infrarenal neck in a real world setting.

Conditions

  • AAA - Abdominal Aortic Aneurysm

Interventions

DEVICE

Endurant Chimney Graft Technique

Medtronic Endurant II and Endurant IIs Stent Graft Systems and balloon-expandable covered stent graft systems approved for use in the renal arteries. These devices will be utilized in a chimney graft configuration.

Sponsors & Collaborators

  • Medtronic Cardiovascular

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-10-26
Primary Completion
2026-03-31
Completion
2030-07-31

Countries

  • Austria
  • France
  • Germany
  • Greece
  • Italy
  • Netherlands
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • Switzerland
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03320252 on ClinicalTrials.gov